ArticleNeuro-ophthalmology (Aeolus Press)2026
Characterisation of Ocular Manifestations in Patients with Multiple Sclerosis in Colombia: A Multicentric Study.
Article in Neuro-ophthalmology (Aeolus Press), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To describe the ocular manifestations in multiple sclerosis (MS) patients in Colombia. We conducted a retrospective observational study of electronic medical records from MS patients evaluated at three referral centres in Bogotá, Colombia, between 2013 and 2020. Inclusion criteria comprised adult patients diagnosed with MS, confirmed by neurologists following the 2017 McDonald criteria. Data on patient demographics, MS phenotypes, ocular symptoms, clinical findings, and treatments were collected from the clinical charts and analysed using descriptive statistics. Optic neuritis was the most common ocular condition (34.1%), followed by glaucoma (6.1%) and nystagmus (4.5%). Other reported conditions included nerve palsies, uveitis, retinal vasculitis, and scleritis (0.8%-2.3%). Of the 618 MS patients reviewed, 132 (19.4%) had ocular manifestations reported. Most were female (71.2%), with a mean age of 34.9 ± 11.8 years. Ocular manifestations were frequent in patients with MS in this Colombian sample. Optic neuritis is the most common, but glaucoma and other ocular pathologies can also develop. Therefore, due to the frequent co-occurrence of these conditions, patients with MS or optic neuritis should have rigorous follow-up care coordinated between ophthalmologists and neurologists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.